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Abstract: 
Objective  
Systematic reviews of mistletoe therapy (MT) trials in cancer show 
promising results in improvement of patients’ quality of life during 
chemotherapy and reduction of fatigue. However patients’ experiences of 
side effects, the acceptability, tolerability and perceived benefits of MT 
have not been systematically reviewed. The aim of this study is to 
systematically review and synthesise the results of qualitative studies of 
cancer patients’ experiences of using MT.  
Design  
A systematic search was conducted in Medline, Embase, Psychlit, Cinahl 
and AMED to identify qualitative studies of MT. Articles were screened 
independently by two reviewers and critically appraised using the CASP 
tool. A thematic synthesis of the findings was carried out.  
Results  
173 papers were identified, 156 were excluded at initial screening. 
Seventeen papers were read in full, 14 of which were excluded. Three 
articles about patients’ experiences of MT alongside conventional treatment 
were included in the synthesis, either as a mono-therapy (two articles) or 
as part of a package of anthroposophic treatment (one article). Patients 
reported demonstrable changes to their physical, emotional and psycho-
social wellbeing following MT, and a reduction in chemo-therapy side-
effects. Self-reported side-effects from MT were few, and the studies 
suggest good adherence to the therapy. Self-injection gave patients a 
sense of empowerment through involvement in their own treatment.  
Conclusions  
A systematic search revealed a small number of qualitative studies of MT in 
cancer. These were effectively combined to provide a detailed overview of 
patients’ experiences, to complement the developing evidence base from 
trials. Given the variation in context of MT delivery across the articles it is 
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not possible to ascribe changes in patients’ quality of life specifically to MT. 
The results of this review will help design outcome measures that more 
fully capture patients’ experiences. It is essential to embed qualitative 
research of patients’ experiences of MT and other CAM therapies within 
future trials.  
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Abstract  
Objective 
Systematic reviews of mistletoe therapy (MT) trials in cancer show promising results in 
improvement of patients’ quality of life during chemotherapy and reduction of fatigue. 
However patients’ experiences of side effects, the acceptability, tolerability and perceived 
benefits of MT have not been systematically reviewed. The aim of this study is to 
systematically review and synthesise the results of qualitative studies of cancer patients’ 
experiences of using MT. 
Design 
A systematic search was conducted in Medline, Embase, Psychlit, Cinahl and AMED to 
identify qualitative studies of MT. Articles were screened independently by two reviewers 
and critically appraised using the CASP tool. A thematic synthesis of the findings was carried 
out.  
Results 
173 papers were identified, 156 were excluded at initial screening. Seventeen papers were 
read in full, 14 of which were excluded. Three articles about patients’ experiences of MT 
alongside conventional treatment were included in the synthesis, either as a mono-therapy 
(two articles) or as part of a package of anthroposophic treatment (one article). Patients 
reported demonstrable changes to their physical, emotional and psycho-social wellbeing 
following MT, and a reduction in chemo-therapy side-effects. Self-reported side-effects from 
MT were few, and the studies suggest good adherence to the therapy. Self-injection gave 
patients a sense of empowerment through involvement in their own treatment. 
Conclusions  
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A systematic search revealed a small number of qualitative studies of MT in cancer. These 
were effectively combined to provide a detailed overview of patients’ experiences, to 
complement the developing evidence base from trials. Given the variation in context of MT 
delivery across the articles it is not possible to ascribe changes in patients’ quality of life 
specifically to MT. The results of this review will help design outcome measures that more 
fully capture patients’ experiences. It is essential to embed qualitative research of patients’ 
experiences of MT and other CAM therapies within future trials. 
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Introduction  
Mistletoe has long been used in the treatment of a variety of acute and chronic conditions 
and has been used in the treatment of cancer since the 1920’s.1 It is given to patients either 
as the central component of a complex, broader treatment regimen in the practice of 
anthroposophic medicine,2 mainly in Europe, or as a single herbal treatment agent outside  
the  context of anthroposophic care. In the treatment of malignancies, it is most often used in 
conjunction with conventional treatments: surgery, radiotherapy and chemotherapy. It is 
given both prior to, concurrently and after these treatments, to reduce adverse reactions and 
improve quality of life. 
A Cochrane review of mistletoe in oncology included 21 randomised controlled trials. 3 The 
recommendations of this review included replication of “two trials suggesting beneficial 
effects of mistletoe extracts on QoL of breast cancer patients during chemotherapy”.  A 
further systematic review of mistletoe therapy for cancer treatment which focused on QoL 
outcomes included 26 randomised controlled trials (RCTs) and 10 controlled trials. 4 The 
authors reported that the results of the RCTs showed improvement in QoL measures in 22 of 
the trials, three showed no differences and one did not report. In 2012, a systematic review 
was published focusing on the mistletoe preparation, Iscador®.5 A random-effect meta-
analysis of 13 controlled studies of which nine were RCTs estimated an overall short-term 
treatment standardised mean effect of 0.56 (95% CI 0.41, 0.71), p<0.0001 but emphasised 
that the methodological quality of studies was poor. There is some evidence that mistletoe 
might be particularly valuable in combating cancer fatigue, a debilitating side-effect of cancer 
and its treatment for which there are limited therapeutic strategies at present.6 
 
A recent survey carried out in 11 European countries including the UK showed that 46% of 
women with breast cancer had used herbal medicine since diagnosis. 7 In the UK, overall 
complementary and alternative medicine (CAM) use by breast cancer patients was 38% but 
the proportion using herbal medicine is unknown. A recent qualitative meta-ethnography of 
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patient’s experience of using CAM after a diagnosis of cancer showed that improving 
wellbeing and quality of life (QoL), dealing with symptoms and finding relief from the side 
effects of treatment were important motivating factors towards CAM use. 8 
In the light of the increasing interest by patients and health professionals for using CAM in 
supportive cancer care and the evidence from mistletoe trials, it is important to further 
explore the patients’ experience of mistletoe therapy. One limitation of previous studies is 
the reliance on alidated quality of life scales as outcome when the consensus regarding the 
definition of QoL for cancer is by no means established. 6 This highlights the need for 
qualitative studies to gauge the significance of the mistletoe treatment from the patient’s 
point of view in terms of its benefit, acceptability and tolerability. Therefore, in this systematic 
review of qualitative studies, we aimed to articulate the experiences of cancer patients when 
using mistletoe. The review was guided by the research question ‘what are cancer patients’ 
views on and experiences of the use of mistletoe therapy (MT)?’  
Methods 
The review had four stages: (1) scoping the topic, (2) systematic literature search, (3) critical 
appraisal, (4) synthesis of findings. 
Scoping the topic 
The SPIDER tool was used to scope the topic.9 This tool comprises five items: Sample, 
Phenomenon of Interest, Design, Evaluation, Research type. Using this tool the inclusion 
and exclusion criteria were determined and in turn the search strategy written.  
The inclusion criteria were:  (i) studies of adult cancer patients regarding the use of 
anthroposophic mistletoe preparations by any administration route as a monotherapy or as 
part of a complex intervention  (ii) studies of qualitative design such as focus groups, 
interviews and questionnaires with free text sections which describe views, experiences or 
opinions of cancer patients and health professionals; (iii) studies in all languages.  
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The exclusion criteria were: (i) studies of paediatric cancer patients (ii) studies of 
anthroposophic therapies that did not involve mistletoe; (iii) studies which included 
questionnaires concerning quality of life yielding quantitative data only. 
Systematic literature search 
The parent search strategy was devised and run in Medline & Medline in process (Figure 1). 
Modified search strategies based on this parent search were run in Embase, Psychlit, Cinahl 
and AMED from database inception until 21st November 2012. The search was up-dated to 
17th April 2015 and no new articles were found that matched our inclusion criteria. The 
reference lists of papers that reached the full paper stage were screened for any extra 
studies. Authors that had at least three mistletoe publications in our search results were 
contacted in order to find out about any publications that we might have missed and to 
provide information on any current studies.  Proceedings from mistletoe conferences were 
screened for extra studies at www.mistelsymposium.de. The website anthromed.org was 
also screened. This site includes past issues of the Journal of Anthroposophical Medicine 
from 1982-1999. 
References from the searches were screened independently by two of the authors and then 
collated. Any disagreements or queries were resolved by a third author. The references were 
first screened by title and abstract and then those of interest were obtained as full papers 
and the second screening was conducted by reading the full text paper.  
Critical Appraisal 
Papers that met the inclusion criteria were assessed for quality using the CASP screening 
tool.10  
Synthesis 
Synthesis of qualitative studies involves a rigorous process of data extraction to identify the 
key concepts from each article.11 There are many methods for synthesising qualitative 
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research.1213 We used the approach of thematic synthesis to combine the studies. 14 
Thematic synthesis has three stages: the coding of text line-by-line; the development of 
descriptive themes and the generation of analytic themes. Descriptive themes are drawn 
directly from the primary studies and analytic themes represent a stage of interpretation 
whereby the reviewers ‘go beyond’ the primary studies and generate new interpretive 
constructs. Two authors (ME and SB) independently extracted data from the included papers 
using line-by-line coding to initially identify descriptive themes. These were drawn from 
verbatim quotations from participants describing their views, accounts and interpretations of 
their experiences of using MT, and from themes identified by the authors of the articles, 
giving their views and interpretations of that data.   
These data extraction sheets were compared between the two reviewers and consensus 
reached. The descriptive themes were listed in an Excel spreadsheet and then synthesised 
to develop analytic themes. These comprise the authors’ interpretations of concepts 
occurring across the articles.  Table 3 lists the analytic themes and shows which descriptive 
themes in each of the articles contributed to them. 
 
Results 
Screening of articles  
From the searches, 173 papers were identified and no additional papers were gained from 
contacting authors.156 were excluded at the title and abstract screening stage. The 
remaining 17 papers were read in full and further screening took place. Three articles 
relating to patients’ experiences of mistletoe were included in the review.15-17 (see PRISMA 
diagram, Figure 2).  One of these, written in German, was translated into English.15 
Critical Appraisal 
Page 8 of 31
Mary Ann Liebert Inc., 140 Huguenot Street, New Rochelle, NY 10801
Journal of Alternative and Complementary Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only; Not for Distribution
  Cancer & mistletoe systematic review  
 8 
 
The quality assessment of the included articles is summarised in Table 1. One paper relied 
on content analysis of interviews which can lack depth of interpretation.17Data for another 
article was drawn from a closed group undergoing psychotherapy who may not reflect the 
views of typical patients.15 No authors reflected on the role of researcher-patient relationship. 
However, despite these limitations, in line with other qualitative syntheses we were reluctant 
to exclude a paper on the basis of reporting quality alone as it might still be relevant to the 
synthesis. We evaluated each paper on the approach of Dixon-Woods et al.18 Out of the 
three included articles, one could be classified as a ‘Key Paper’ in terms of its relevance to 
the overall research question despite some quality limitations and two were ‘Satisfactory’. All 
three articles provided a rich resource of primary data for the purpose of synthesis. 
Study descriptions 
The three included articles varied in methodology and content. Study characteristics are 
given in Table 2. In the  Konitzer study, MT was provided as a mono-therapy in general 
practice supported by regular group therapy sessions.15 In the Arman et al. study, MT was 
embedded in an individually prescribed package of anthroposophic care at a specialist 
clinic.16 This included ‘natural remedies (herbs, plant extracts, essential oils, potentized 
natural substance)’. This study included a mixed sample of patients some of whom were 
being treated for cancer and some for ‘burn-out syndrome’, but the data analysis did not 
distinguish between the two groups. In the Brandenberger et al study MT was given as an 
out-patient mono-therapy at a private integrative hospital. 17  
Mode of delivery of MT varied: one study used infusions,15 one used sub-cutaneous 
injections,17 one did not report methods of administration.16 Data collection in two of the 
studies was by individual interview.16,17 In the third, patients were asked to draw pictures of 
MT and talk about their experiences during an ongoing group therapy session.15 All articles 
provided data on aspects of patients’ experience of MT, reporting directly on perceived 
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changes in wellbeing16,17 and in one article relating this symbolically to the nature of the 
mistletoe plant from which the extract is derived. 15  
Overview 
MT patients reported improvements to their physical, emotional and psycho-social wellbeing, 
and felt able to construct meaning from the experience of the disease and its treatment.   
Six analytic themes were identified that encompassed all the relevant data in the articles and 
provided a synthesis across all three. Table 3 shows the concepts that emerged from each 
paper and contributed to the themes. It is not possible to distinguish the effects of MT from 
other aspects of the holistic package in the Arman et al.16 However, patients’ verbatim 
quotations were chosen where possible with specific reference to their experience of MT. 
The themes were: ‘Treating the inner and outer worlds’, ‘Moving from darkness into light’, 
‘Taking control and increasing personal autonomy’, ‘Tangible outcomes’, ‘Ambivalence about 
MT’,  ‘Bridging the gap between conventional and integrative care’.  
Verbatim quotations from the articles are used to illustrate the themes. Most quotations 
directly report the patients’ words. Where the authors’ words are quoted this is marked 
[authors]. 
Treating the inner and outer worlds 
The experience of receiving MT appears to be intimately connected to a sense of both the 
outer and inner worlds of the patient being nurtured and treated in a ‘holistic’ way. MT was 
perceived as an agent that works with body, mind and spirit.  Treatment involved intense 
personal contact with health professionals in a relatively ‘low-tech’ environment so that 
patients felt they were fully ‘seen’ by their carers. Staff provided holistic care and attention 
which was then mirrored by the patients who became more self-reflective, focussing on their 
inner needs as a precursor to growth and change.16 This stimulated memories of childhood, 
like a return to ‘mother’s cradle’, a place where fear was diminished.15,16  Patients felt able to 
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rest in a comfortable place, exemplified by one patient who physically lay down after each 
mistletoe injection.15  
MT was perceived as a powerful positive force under-pinning many of the outcomes 
described by patients, as captured in one article with phrases such as ‘mistletoe is a sincere 
agent’, ‘like a small saviour out of the vicious circle’.15 The qualities of mistletoe in the wild 
were found to support its use as a treatment, and patients perceived MT to be redolent of 
healing energy: the corresponding energy could only now be set free, so that I can finally 
come to my truth, to what I am ‘.’ 17 
Patients described MT as providing a turning-point in their experience of disease and 
increasing their self-awareness:  ‘Patients were able to return to their own inner path, 
returning to their inner sources and discovery of basic values of their own lives’ [authors].16 
Brandenberger refers to ‘internal changes’ [authors] that helped patients to develop a greater 
sense of hope and ability to cope: ‘Mistletoe therapy was adopted by the study patients 
mostly with a supportive aim and seemed to offer a platform for an integrative coping with 
the disease, which in itself is likely to have helped the cancer patients, inasmuch as it gave 
them hope and probably increased their motivation to deal with this devastating disease.  
During MT, the patients often perceived an improvement of QoL which was associated with 
a higher vitality and autonomy and translated into clear-cut personal achievements [authors]. 
The interviewer noted that patients were more talkative, self-reflective and positive at second 
interview, following MT. 
Life and vitality were seen as returning through a process that involved first of all patients 
allowing themselves to ‘be sick’[authors] 16 and letting the disease then become their 
‘teacher ... who shows me what is happening with me at each moment’. The perceived 
transformative power of MT is emphasised by comments like ‘I have experienced this myself’ 
as a way of vouching for the credibility of the patient’s story.15 
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Moving from darkness into light 
The changing inner world of cancer patients receiving MT was conceptualised as moving 
from ‘darkness’ or a ‘dreadful hole’ into ‘light’.15,16 In both these papers MT is conceptualised 
as bright, warm, light, ‘golden’, a provider of energy akin to the sun. The experience was 
enhanced by injection as the mode of delivery, with patients describing a sense of the 
healing energy of mistletoe flowing into their body. Patients reported a reduction in ‘dark 
thoughts’ and fear, with a lightening in their mood state to an increased sense of ‘joie de 
vivre’15 or cheerfulness and an ability to see ‘light at the end of the tunnel.’16 This contrasted 
with a previous focus on ‘duty’ and ‘survival’. The metaphor of ‘lightness’ encompassed their 
attitude to life more generally, ‘not taking things as seriously as before.’ 17 For some it led to 
improved personal relationships, an experience described as ‘liberation.’ 17  There was an 
effect on patients’ attitude to life more generally: ‘Yes this is a whole new phase for me, it’s 
like I’ve become a brand new person afterwards, in a way.’ 16 MT helped patients to make 
changes in their lives, convert ideas into actions and re-assess their priorities such as 
spending more time with their partner or setting limits to their professional life and reducing 
stress: I now feel in terms of close relationships that I don’t always have to be everywhere ... 
I can set boundaries for myself ... it’s a relief.’17 
Taking control and increasing personal autonomy 
The ritual of self-injection provided a sense of personal empowerment through active 
participation in the treatment process and gave patients a sense of control, particularly when 
conventional treatment ended. The injections functioned as a regular reminder of the 
disease and helped patients to become more accepting of its presence, also bringing them 
closer to family members: ‘In some cases, MT seemed to bring together family members, 
who until then had had different opinions on therapeutic choices or on disease perception, 
thereby fulfilling psychosocial functions ... it is likely that MT might have played a role in 
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improving quality of life ... a chance to consider personal preferences, concepts and settings 
to integrate the help of their loved ones’ [authors]. 17 
Following MT, patients reported feeling less vulnerable and more assertive about getting 
their personal needs met, such as ensuring that their own daily rhythms and coping 
mechanisms being respected by health professionals and employers. Patients felt less 
constrained by conventional ways of behaving and were able to establish personal priorities 
and boundaries more clearly, leading to ‘more genuine ways of living [authors]. 16 This 
improved sense of personal autonomy enabled patients to start new projects in their lives 
and reduce their experience of subjective stress. 
Tangible positive outcomes  
Patients in all three articles reported tangible, potentially measurable, changes following MT 
in their physical and psychological wellbeing and a reduction in side effects of cancer and its 
treatment: ‘The hair loss stopped! The side effects of the chemotherapy were less. I felt 
(feel) good!’ 15 Some patients reported almost no side effects when undergoing 
chemotherapy and MT simultaneously and ‘reported doing better after 3 months’ of MT 
[authors]. 17  
Patients reported emerging from therapy with a stronger vitality’ ‘new’ view of life, with new 
priorities and ‘tools for living a healthy life’ such as a good diet, the importance of rest and 
therapeutic exercises. 16 MT was seen as a ‘health supporter’ leading to pain reduction, and 
less colds, suggesting improved immune function. Increased emotional stability, less 
depression and improved strength and energy led to new personal achievements and re-
gaining of function: ‘I got the mistletoe one I was quickly back on my legs again ... I can say, 
because I got nothing else [only mistletoe]. I really did feel it and I was in a terrible hole then, 
and I was absolutely not getting back up again and yet this has me completely back up.’ 15   
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Patients gave example of tangible changes such as quitting a stressful job and accepting 
part-time employment, setting up a new horse stable, buying a computer in order to self-
educate about cancer, chopping wood, booking tickets for travel and seeking information 
from other cancer sufferer: ‘I don’t fear anything – absolutely nothing; I don’t have dark 
thoughts ... I feel fine and I have my projects ... and I have a new computer.’ 17 
 
Ambivalence about MT 
Decisions to use MT were mixed, sometimes driven by a lack of viable alternatives and a 
feeling that ‘any therapy is better than none’, particularly if conventional medicine had not 
helped and patients were hoping for improved disease outcome. Anthroposophic medicine, 
including MT was for some a mere ‘snatching at straws’ and was challenging for those who 
had to ‘overcome prejudice for another paradigm’ that lay outside conventional medicine. 16,17 
 
In the context of mostly positive feedback, some patients expressed uncertainty about 
whether changes they experienced could be attributed solely to MT, data which are 
unsurprising given the context of multi-modal treatments. In Brandenberger’s article only 
three patients at interview attributed their improvements explicitly to MT. It was difficult to tell 
whether, for example, chemotherapy side-effects might have been worse without MT. 
Patients undergoing chemotherapy and MT simultaneously reported having almost no side 
effects and doing better after the 3-month period of MT. This improvement could be 
attributable to MT, successful chemotherapy or diminishing side-effects over time. Accounts 
of negative experience of MT were rare. One patient reported a decrease in QoL during MT 
and died shortly after interview due to progression of the disease. Nevertheless, this patient 
reported that he still had hope and his spouse—who participated in the interview—felt ‘that 
she and her husband had become closer to each other because of the process of choosing 
and doing MT together.’ 17 
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Symbolic reference in the Konitzer article to the nature of the mistletoe plant illustrates this 
ambivalence. The parasitic plant can be likened to a cancer itself whilst it is also 
conceptualised as a bringer of light, energy and health. There were some reported side-
effects of MT, such as redness and hardening at the injection site particularly following a 
high concentration or repeated injection at the same site. Local reactions such as these are 
expected with MT. One patient reported a systemic reaction: tiredness, fever, muscle aches, 
sleeplessness, and problems with concentration. However no patients in any of the three 
studies interrupted MT because of these reactions, although one patient reported feeling 
‘relieved’ when the treatment and the associated side-effects ended. 
Bridging the gap between conventional and integrative care 
This theme is derived only from the Arman article but is relevant to the wider literature on 
integrative medicine. Arman points to a mutual scepticism between practitioners of 
conventional and anthroposophic health care, also evident amongst some patients, 
exemplified by one who expressed difficulty in ‘opening up’ to the idea of MT and 
‘overcoming prejudices’. In this article, patients were seen as having to do the work of being 
‘bridge-builders’ between the two systems, carrying ‘the burden and the risk which may 
cause stress’ [authors]: ‘The gap implies a lack of knowledge and occasionally ignorance on 
both sides. Patients have to bridge the gap by themselves ... they feel like they are standing 
with one foot on each side’ [authors]. 
Discussion 
This systematic review has revealed a small number of qualitative studies of MT, which is in 
sharp contrast to the number of clinical and laboratory-based studies. The initial searches 
also revealed a total absence of studies investigating health professionals’ attitudes to the 
use of MT, a key question for the transferability of MT to other clinical and international 
settings where it is not currently used.  
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This review does reveal a coherent narrative of patients’ experience of MT despite diverse 
types of data drawn from the primary studies. All the articles were based in Northern Europe 
and further studies may be needed of the appropriateness of MT in other in other contexts. 
Although these three studies of the use of MT are a rich source of patient-centred 
information they are small-scale and exploratory. Synthesis of the findings gives added value 
by combining the insights gained in individual papers, and thereby gives a stronger 
indication of the likely impact of MT on patients. There was a multiplicity of ways in which MT 
was experienced and benefits were mediated via the symbolic nature of the mistletoe plant 
itself, the ritual of self-injection and the physiological impact of the therapy. It is not possible 
to clearly distinguish the effects of MT from other aspects of the holistic package in the 
Arman et al article.16 
The data may reflect the particular context of MT delivery. Patients’ descriptions of their 
experiences of MT in two of the articles were likely to have been influenced by the 
anthroposophic context of their treatment, in one case receiving a package of anthroposphic 
treatment 16 and in the other receiving group analytic therapy.15 However in the 
Brandenberger et al article patients received MT in an integrative medicine setting where MT 
was combined with conventional rather than anthroposophic medicine. Significantly, all but 
two of the themes emerged from data across all three articles, suggesting a communality of 
experience. 
There were many specific examples of a reduction in side-effects of chemotherapy and 
improvements in wellbeing such as improved mood and increased energy which are 
consistent with clinical trials and cohort studies. Patients’ narratives went beyond the 
physical improvements into emotional and psycho-social benefits and the construction of 
meaning around their disease.  
The fact that patients at interview were unwilling or unable to decisively ascribe these 
improvements to MT is not surprising given the multi-modal treatments that they were 
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receiving. However, despite some initial scepticism and some experience of side-effects, the 
data suggest that patients’ adherence to MT was impressive in these studies which 
reinforces the importance that patients gave to the treatment.  This review captures 
important insights into changes that were meaningful for patients and underlines the 
limitation of relying on quantitative measures of quality of life alone.  
The importance of MT as a means of gaining a sense of control is consistent with reports in 
the literature on the use of complementary and alternative therapies in cancer.19 Self-
injection enhances the experience of patient participation in their own treatment and 
participation has been shown to improve mood and psychological coping and may impact on 
survival.20 
 
One of the articles highlights the mutual professional scepticism across disciplinary 
boundaries between conventional and integrative medicine, with patients feeling they have 
to form a ‘bridge’. Such institutional polarisation has previously been reported as a barrier for 
patients in achieving a positive experience of complementary therapies in cancer care.4 This 
issue needs to be addressed through education for health care providers if MT use were to 
be extended to clinical settings outside of central Europe. 
Limitations to the review 
The focus of two of the articles was indirectly rather than directly relevant to the research 
question, one reporting on symbolic understanding of mistletoe and the other on a package 
of anthroposophic care, not just MT. Some of the data sources were ‘non-standard’, for 
example material gathered from a therapy group, including the use of art therapy material.15 
It is, difficult to separate the experience of MT from the context in which it was delivered. In 
all three studies MT was part of a multi-modal approach to cancer treatment that included 
conventional care and other, unspecified, complementary therapies. 
Page 17 of 31
Mary Ann Liebert Inc., 140 Huguenot Street, New Rochelle, NY 10801
Journal of Alternative and Complementary Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only; Not for Distribution
  Cancer & mistletoe systematic review  
 17 
 
The mode of delivery and dosage of mistletoe treatment were different in each of the 
articles. The Arman study included a mixed sample of patients some of whom were being 
treated for cancer and some for ‘burn-out syndrome’, but the data analysis did not 
distinguish between the two groups. 
Conclusions 
The results of this review suggest that MT is well tolerated by patients who reported good 
adherence to the therapy and articulated a range of important benefits in their physical and 
psycho-social well-b ing. In line with patients’ comments it is important to acknowledge that 
we cannot necessarily ascribe the benefits directly to MT in the context of other therapies 
being received, although references specifically to MT were frequent across articles. 
Patients also welcomed active participation in treatment through self-injection.  
Further good quality qualitative studies of MT need to be carried out and it is essential to 
embed qualitative research of patients’ experience within  future trials of MT. A qualitative 
approach to health professionals’ views on MT would add an important dimension, 
particularly within conventional care settings where anthroposophic medicine is not the 
norm. A major goal for future research should be the disentangling of MT from the context of 
delivery. Given the high prevalence of cancer, the expanding range of treatment options and 
increased survivorship MT should be more widely assessed through well designed trials as a 
potential adjunctive treatment in supportive cancer care, with high quality focussed 
qualitative research as an essential element.  
Author Disclosure Statement: No competing interests 
Author contributions:  ME, GF & AH were involved in the conception of the review. AH 
lead on the written methods section and carried out the electronic searches. ME, SB & AH 
screened the references. ME led the qualitative data extraction and drafted the results and 
discussions. SB and ME completed the data extraction and synthesis. GF made a 
Page 18 of 31
Mary Ann Liebert Inc., 140 Huguenot Street, New Rochelle, NY 10801
Journal of Alternative and Complementary Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only; Not for Distribution
  Cancer & mistletoe systematic review  
 18 
 
substantial contribution to drafting the manuscript. All authors contributed to the final 
manuscript. 
Authors’ information: ME and AH are research fellows, SB a research associate, and GF 
is a professor at the Centre for Academic Primary Care, University of Bristol. GF is also a 
general practitioner. 
Acknowledgements: This article is part of a pilot study for a randomised controlled trial of 
mistletoe use in breast cancer, funded by the National School for Primary Care Research. 
  
Page 19 of 31
Mary Ann Liebert Inc., 140 Huguenot Street, New Rochelle, NY 10801
Journal of Alternative and Complementary Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only; Not for Distribution
  Cancer & mistletoe systematic review  
 19 
 
 
References 
1. Kienle, Kiene, Albonico. Anthroposophic Medicine, Schattauer 2006 ISBN 3-7945-
2495-0. 
2. Kienle GS. The story behind mistletoe: a European remedy from anthroposophical 
medicine. Altern Ther Health Med 1999; 5:34-6. 
3. Horneber MA, Bueschel G, Huber R, Linde K, Rostock M. Mistletoe therapy in 
oncology. Cochrane Database Syst Rev 2008; (2):CD003297. 
4. Kienle GS, Kiene H. Influence of Viscum album L (European mistletoe) extracts on 
quality of life in cancer patients: a systematic review of controlled clinical studies. 
Integr Cancer Ther 2010; 9:142-57.  
5. Büssing A, Raak C, Ostermann T. Quality of life and related dimensions in cancer 
patients treated with mistletoe extract (iscador): a meta-analysis. Evid Based 
Complement Alternat Med. 2012; ID:219402 doi10.1155/2012/219402 
6. Eisenbraun J, Scheer R, Kröz M, Schad F, Huber R. Quality of life in breast cancer 
patients during chemotherapy and concurrent therapy with a mistletoe extract. 
Phytomedicine 2011; 18:151-7. 
7. Molassiotis A, Scott JA, Kearney N et al.  Complementary and alternative medicine 
use in breast cancer patients in Europe. Support Care Cancer 2006; 14:260-7.  
8. Smithson J, Britten N, Paterson C, Lewith G, Evans M. The experience of using 
complementary therapies after a diagnosis of cancer: a qualitative synthesis. Health 
(London). 2012; 16:19-39.  
9. Cooke A, Smith D, Booth A.  Beyond PICO: the SPIDER tool for qualitative evidence 
synthesis. Qual Health Res 2012; 22:1435-43.  
10. http://www.casp-uk.net/wp content/uploads/2011/11/CASP_Qualitative 
_Appraisal_Checklist_14oct10.pdf accessed January 2013. 
Page 20 of 31
Mary Ann Liebert Inc., 140 Huguenot Street, New Rochelle, NY 10801
Journal of Alternative and Complementary Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only; Not for Distribution
  Cancer & mistletoe systematic review  
 20 
 
11. Bennion AE, Molassiotis A. Qualitative research into the symptom experiences of 
adult cancer patients after treatments: a systematic review and meta-synthesis. 
Support Care Cancer 2013; 21:9-25.  
12. Dixon-Woods M, Agarwal S, Jones D, Young B, Sutton A. Synthesising qualitative 
and quantitative evidence: a review of possible methods. J Health Serv Res Policy 
2005; 10:45-53. 
13.  Thorne S, Jensen L, Kearney MH, Noblit G, Sandelowski M  Qualitative 
Metasynthesis: Reflections on Methodological Orientation and Ideological Agenda. 
Qual Health Res 2004; 14: 1342-65 
14. Thomas J &  Harden A. Methods for the thematic synthesis of qualitative research in 
systematic reviews. BMC Medical Research Methodology 2008; 8: 45 
15. Konitzer M, Doering T, Fischer GC. Metaphorical aspects of mistletoe therapy in 
patients' experiences--a qualitative study. Forsch Komplementarmed Klass 
Naturheilkd 2001; 8:68-79. German.  
16. Arman M, Ranheim A, Rehnsfeldt A, Wode K. Anthroposophic health care--different 
and home-like. Scand J Caring Sci 2008; 22:357-66. 
17. Brandenberger M, Simões-Wüst AP, Rostock M, Rist L, Saller R. An exploratory 
study on the quality of life and individual coping of cancer patients during mistletoe 
therapy. Integr Cancer Ther 2012;11:90-100 
18. Dixon-Woods M, Sutton A, Shaw R et al.  D. Appraising qualitative research for 
inclusion in systematic reviews: a quantitative and qualitative comparison of three 
methods. J Health Serv Res Policy 2007;12:42-7 
19. Truant T, Bottorff JL. Decision making related to complementary therapies: a process 
of regaining control. Patient Educ Couns 1999; 38:131-42. 
20. Sollner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P. Use of 
complementary and alternative medicine by cancer patients is not associated with 
Page 21 of 31
Mary Ann Liebert Inc., 140 Huguenot Street, New Rochelle, NY 10801
Journal of Alternative and Complementary Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only; Not for Distribution
  Cancer & mistletoe systematic review  
 21 
 
perceived distress or poor compliance with standard treatment but with active coping 
behaviour: a survey. Cancer 2000; 89: 873–880.) 
Corresponding Author: Dr Maggie Evans 
Centre for Academic Primary Care, School of Social and Community Medicine  
University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS 
Email: m.a.evans@bristol.ac.uk    
Page 22 of 31
Mary Ann Liebert Inc., 140 Huguenot Street, New Rochelle, NY 10801
Journal of Alternative and Complementary Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only; Not for Distribution
Table 1: Summary of CASP quality assessment of included papers 
Article Was there 
a clear 
statement 
of the 
research 
aims? 
Is a qualitative 
methodology 
appropriate? 
Was the 
research 
design 
appropriate 
to address 
the aims of 
the 
research? 
Was the 
recruitment 
strategy 
appropriate 
to the aims 
of the 
research? 
Were the 
data 
collected 
in a way 
that 
addressed 
the 
research 
issue? 
Has the 
relationship 
between 
researcher 
and 
participants 
been 
adequately 
considered? 
Have 
ethical 
issues 
been 
taken 
into 
consider-
ation? 
Was the 
data analysis 
sufficiently 
rigorous? 
 Is there a 
clear 
statement 
of 
findings? 
Is the 
research 
valuable
? 
Key Paper or 
Satisfactory 
Paper 
Arman et al 
2007
16
 
Y Y Y Y Y N Y Y Y Y SAT 
Brandenberger 
et al 2011
17
 
Y Y Y Y Y N Y N Y Y KP* 
Konitzer et al 
2001
15
 
Y Y Y Y Y N N Y Y Y SAT** 
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NB: Final column uses Dixon-Woods appraisal criteria 
*KP: A Key paper is conceptually rich and could potentially make an important contribution to the synthesis 
**SAT: A Satisfactory Paper may provide less conceptual relevance to the synthesis 
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Table 2:  Study description table             
Study  Aim Setting Theoretical 
approach  
Methods Sample, age 
and gender 
Type of cancer Types of therapy 
Arman et al  
 
 2008 
16  
 
Sweden 
1) To deepen  
understanding of 
what constitutes 
good care from 
a patient’s 
perspective to 
alleviate patient 
suffering &  
identify clinical 
markers for this 
2) To explore 
what in 
anthroposophic 
care is 
experienced as 
being beneficial 
or difficult 
12-21 days 
spent as in-
patient at 
anthroposophic  
clinic  
Clinical 
application 
research, 
participatory and 
action research.  
Narrative 
interviews in 
patients’ homes 
2-4 weeks after 
stay in the clinic  
 
n= 16 
 
Cancer n=9 
 
Age range 50-72 
 
Male (5)  
Female (4) 
 
Burn-out 
syndrome n= 7  
 
Age range 32-58 
 
Male (4)  
Female (3) 
 
Locally limited n=3 
 
Recurrent n=6  
 
Time since 
diagnosis 1-3 yrs. 
 
An individually prescribed 
package of anthroposophic 
care, one element of which 
consisted of herbs and 
plants extracts including 
Iscador (mistletoe). 
 
Mode of delivery of MT not 
stated 
 
No reference to where and 
when patient received 
conventional treatment 
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Brandenberger 
 
 2011 
17
 
 
Switzerland 
What are 
patients’ 
expectations & 
experiences of 
mistletoe 
therapy (MT) 
and its effects 
on quality of life 
 
 
MT given to 
hospital out-
patients at an 
integrative 
hospital 
Mixed methods. 
exploratory, 
prospective, 
before/after 
cohort study 
using standard 
QoL 
questionnaires 
and interviews. 
Content and 
theory 
generating 
analysis.  
Patient 
interviews at 
start of MT and 
3 mths later in 
hospital or other 
location of 
patient’s choice  
n=17 (12 sets of 
repeat 
interviews 
included in the 
analysis)  
Wider cohort 
study (n=25)  
Mean age 62+/- 
11.1 yrs  
Male (14) 
Female (11) 
Wider cohort study: 
Colorectal n=7 
Prostate n=4 
Breast n=4 
Lung n=3 
Pancreatic n=3 
Melanoma n=1 
Renal n=1 
Myeloma n=1 
Multifocal 
basalioma  n=1 
 
Time since 
diagnosis:   
Ranged 1.5 months 
to >5 years 
Sub-cutaneous injections of 
anthroposophic mistletoe 
preparations 2-3 times per 
week ‘often performed by 
patient’ Iscador (n=13), 
Abnoba viscum (n=11), 
Isorel (n=1). 
 
Conventional treatment : 
Chemotherapy before n=9 
(of which n=6 continued 
chemotherapy during MT) 
Radiotherapy before n=3  
(of which n=2 during MT) 
Hormone therapy n=4 
Other CAM therapies N=2 
Psychotherapy n=1 
No reference to whether 
conventional treatment and 
MT received at the same 
hospital 
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Konitzer 
 
2001 
15 
 
Germany 
To explore 
whether the 
term ‘mistletoe’ 
is associated 
with images of 
‘cancer’ or a 
‘counter-agent 
against cancer’ 
for those 
patients treated 
with it. 
MT given in 
general practice 
over 1.5 years 
1-3 x per week 
 
Grounded 
theory. 
Linguistic data 
triangulated with 
pictures. Data 
triangulated with 
external theories 
on metaphor 
based in the 
work of Steiner, 
Seligman, 
Frazer.  
Patients 
attending a 
weekly 
psychotherapy 
group  session 
during MT were 
asked to draw 
pictures of their  
MT & talk about 
their 
experiences  
n=12 
Mean age: 51.6 
yrs (SD 3.65) 
Gender  
not stated 
Breast cancer n=9 
Uterine cancer n=2 
Hypernephroma 
n=1 
 
Time since 
diagnosis not stated 
Infusions of mistletoe 
extracts: Isorel, Novipharm, 
Portschach 
 
No reference to whether, 
where and when patient 
received conventional 
treatment 
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Table 3: Development of analytic themes   
A = Arman et al B= Brandenberger et al K= Konitzer et al  
Analytic theme Description 
 
Treating the inner and 
outer worlds 
Patients described inner healing and increased self-awareness 
during MT, which was enhanced by positive interactions with 
health professionals 
 
Home-coming A 
 
Mirroring / being 'seen' by caregiver A 
 
Intense personal contact with health professsionals B 
 
Absence of technology A 
 
Return to mother's cradle A 
 
Memories of childhood tastes K 
 
Mistletoe is 'sincere' K 
Comforting environment A, K 
Holistic care A 
Renewed hope and renewed opportunities A 
New priorities A, B 
Let the mask fall and be sick A 
Changing relationship with disease B 
Acceptance of the disease B 
Disease as a teacher B 
More positive attitude B 
Process past events B 
Improved self-awareness B, K 
Inner and outer atmospheres A 
Stronger vitality B 
Mistletoe as a 'saviour' K 
Restitution narrative K 
   Moving from darkness 
into light 
Patients graphically described their change in mood from dark to 
light following therapy, which is mirrored by imagery relating to 
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the sun 
Light at the end of the tunnel A 
Duty and survival to lightness A 
MT associated with the sun K 
Increased cheerfulness and joie de vivre A, K 
Golden mistletoe K 
Moving out of a 'dreadful hole' K 
   Taking control and 
increasing personal 
autonomy 
MT injecting is seen to have ritual significance and the MT itself is 
redolent of healing energy 
Self-injection as a reminder of the disease B 
Self-injection as a small ritual K 
More autonomy, less affected by others B 
Free from conventions B 
Distinguishing important and less important things B 
Changing conditions of subjective stress B 
Getting personal needs met  B 
Drawing together family members B 
Dealing with the disease better A,B 
Active participation in multi-modal treatment B 
   Tangible outcomes External, potentially measurable, changes reported after MT 
Tools for  living a healthy lifestyle A 
New personal achievements B 
Increased motivation to deal with disease B 
Increased emotional stability B 
Reduction in pain B 
Less depression B 
Reduction in frequency of colds B 
Stronger vitality B, K 
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Converting ideas into actions B 
Cutting wood B 
Distinguishing important and less important things B 
Booking travel B 
Staring new projects B 
Increase in personal achievements B 
On my legs again K 
Improve personal relationshps B 
Liberation in personal relationships B 
Solving / limiting professional stress B 
Bringing together family members B 
Ambivalence about MT 
Despite patients' commitment to MT uncertainty is expressed in 
relation to its uptake, its effectiveness and side-effects 
Overcoming prejudice for another paradigm A 
Doubt about  outcomes on disease and QoL A, B 
Doubts about reduction of side-effects of radio-therapy B 
Experience of side-effects of MT B 
Mistletoe looks like cancer in the tree K 
Decrease in QoL B 
   Bridging the gap between 
conventional and 
integrative care  
The perceived gap between conventional and integrative care is 
problematised with patients having to function as a 'bridge' 
 
Contrasting environments of care A 
 
Overcoming prejudice for another pardigm A 
 
Patients as a 'bridge' A 
 
Patients want more integration A 
 
Patients taking 'burden' and 'risk' A 
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Figure 1 
Parent search strategy run in Medline via Ovid  
1. qualitative research.mp. or Qualitative Research/ 
2. questionnaires.mp. or Questionnaires/ 
3. focus groups.mp. or Focus Groups/ 
4. Interview/ or interviews.mp. 
5. Or/1-4 
6. mistletoe.mp. or Mistletoe/ 
7. Viscum album.mp. or Viscum album/ 
8. anthroposoph*.mp. or Anthroposophy/ 
9. 6 or 7 or 8 
10. 5 and 9 
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Figure 2  
PRISMA diagram 
 
 
Records identified through 
database searching  
(n = 219) 
Additional records identified through 
other sources  
(n = 11) 
Records after duplicates removed & 
screened by title & abstract  
(n = 173) 
Full-text articles assessed 
for eligibility  
(n = 17  ) 
Full-text articles excluded, with 
reasons (n = 14 ) 
Not qualitative design or analysis n=10 
Not about patients’ experiences of 
mistletoe n=2 
Not about patients’ experience of 
treatment but of cancer n=1 
Duplicate (article in other language) n=1 
 
Articles included in 
qualitative review  
(n=3) 
Duplicates (n=14) & obviously 
irrelevant* (n=43) excluded 
(n=57) 
*No mention of mistletoe or cancer in 
title & abstract 
Records excluded at title & abstract  
With reasons (n =156)  
Not qualitative design or analysis n=48 
Not cancer patients n=29 
Not including mistletoe n=23  
Not adults/humans n=24 
Not patients (about health profs or other 
experiences) n=18 
Not a research article (conference report, 
review paper, etc) n=9 
Questionnaire validation n=4 
Duplicate article n=1 
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